BioXcel Therapeutics: Q1 Earnings Insights

BioXcel Therapeutics BTAI reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

BioXcel Therapeutics beat estimated earnings by 2.61%, reporting an EPS of $-1.12 versus an estimate of $-1.15.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.17 which was followed by a 4.36% drop in the share price the next day.

To track all earnings releases for BioXcel Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.